Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386
2. Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E (2012) Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 23(Suppl 7):711–719. https://doi.org/10.1093/annonc/mds232
3. Howlader N, Noone A, Krapcho M, Miller D, Bishop K, Kosary C, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DC, Chen HS, Feuer EJ, Cronin KA. (eds) (2016) SEER Cancer Statistics Review, 1975–2014, National Cancer Institute. National Cancer Institute. https://seer.cancer.gov/csr/1975_2014/. Accessed 30 Jan 2018
4. O’Shaughnessy J (2005) Extending survival with chemotherapy in metastatic breast cancer. Oncologist 3(10 Suppl):20–29. https://doi.org/10.1634/theoncologist.10-90003-20
5. Sundquist M, Brudin L, Tejler G (2017) Improved survival in metastatic breast cancer 1985–2016. Breast 31:46–50. https://doi.org/10.1016/j.breast.2016.10.005